Clinical studies recruiting near Edinburgh

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Western General Hospital · Pfizer · NCT07028853 ENDO1000 - A UK-wide Endometriosis Research Project
Phase N/A · University of Edinburgh · University of Edinburgh · NCT07240883 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Western General Hospital ( Site 2607) · Merck Sharp & Dohme LLC · NCT06393374 Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma Wi
Phase 3 · Research Site · AstraZeneca · NCT07509151 A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes
Phase 3 · Royal Infirmary of Edinburgh · Vertex Pharmaceuticals Incorporated · NCT04786262 A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
Phase 3 · Royal Hospital for Children and Young People - PIN · H. Lundbeck A/S · NCT05897320 Fibrosis in Chronic and Delayed Myocardial Infarction
Phase N/A · University of Edinburgh · University of Edinburgh · NCT05756608 Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Phase 1/Phase 2 · Western General Hospital · CellCentric Ltd. · NCT04068597 The Oxford Risk Factors And Non-Invasive Imaging Study
Phase N/A · University of Edinburgh, Royal Infirmary · University of Oxford · NCT05169333 Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832 A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena
Phase 3 · Western General Hospital ( Site 3604) · Merck Sharp & Dohme LLC · NCT07216703 A Study of the Safety and Activity of Sparsentan for the Treatment of Patients With Immunoglobulin A Nephropathy
Phase 2 · Royal Infirmary of Edinburgh & Western General Hospital · University of Leicester · NCT04663204 Hemithyroidectomy or Total-Thyroidectomy in 'Low-risk' Thyroid Cancers
NA · NHS Lothian · University College, London · NCT05604963 A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-
Phase 1 · Western General Hospital · Regeneron Pharmaceuticals · NCT05685173 A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
Phase 1 · Western General Hospital - NHS Lothian · Nuvectis Pharma, Inc. · NCT05873686 A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated E
Phase N/A · Research Site · AstraZeneca · NCT05663515 RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures
NA · Royal Infirmary of Edinburgh · AgNovos Healthcare, LLC · NCT04796350 Cardiovascular Risk Assessment For Kidney Transplantation - Utility of Computed Tomography Coronary Angiography in the A
Phase N/A · Royal Infirmary of Edinburgh · University of Edinburgh · NCT06234410 Mechanisms of Myocardial Injury and Ischemia in Patients With Rapid Atrial Fibrillation
Phase N/A · Royal Infirmary of Edinburgh · University of Edinburgh · NCT06951100 SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Phase 2 · NHS Lothian - Royal Hospital for Sick Children · SAb Biotherapeutics, Inc. · NCT07187531 A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Phase 1 · Edinburgh Cancer Centre, Western General Hospital · Seagen, a wholly owned subsidiary of Pfizer · NCT06131840 Perioperative Pembrolizumab and Lenvatinib in Resectable Hepatocellular Carcinoma (HCC)
Phase 2 · Western General Hospital · University College, London · NCT05185739 Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia
Phase 2/Phase 3 · Scottish Brain Sciences · Exciva GmbH · NCT07284472 Fatigue in Lupus Intervention Programmes (FLIP)
NA · NHS Lothian · University of Edinburgh · NCT06308770 Duroplasty for Injured Cervical Spinal Cord With Uncontrolled Swelling
NA · Royal Infirmary of Edinburgh · St George's, University of London · NCT04936620 Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosi
Phase 3 · Royal Infirmary of Edinburgh · Takeda · NCT05677971 Pan Tumor Rollover Study
Phase 2 · Local Institution - 0299 · Bristol-Myers Squibb · NCT03899155 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06692738 DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adul
Phase 2/Phase 3 · Western General Hospital · Cancer Research UK · NCT05786716 Graft Failure and Consequences of Coronary Artery Bypass Graft Surgery
Phase N/A · Royal Infirmary of Edinburgh · University of Edinburgh · NCT06800430

Look up another city

Look up another condition